Steven J. Rice - 30 Nov 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Administrative Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 30 Nov 2021
Transactions value $: $-372,400
Form type: 4
Filing time: 02 Dec 2021, 16:12:04 UTC
Previous filing: 24 Aug 2021
Next filing: 22 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$127,600	+10,000	+48.5%	$12.76	30,600	30 Nov 2021	Direct	F1
transaction	VIR	Common Stock	Sale	$-500,000	-10,000	-32.7%	$50.00^*	20,600	30 Nov 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-2.3%	$0.000000	424,441	30 Nov 2021	Common Stock	10,000	$12.76	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F3	1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.